Literature DB >> 23615700

End-tidal carbon dioxide and arterial pressure for predicting volume responsiveness by the passive leg raising test: a commentary.

Michael Piagnerelli, Patrick Biston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615700     DOI: 10.1007/s00134-013-2913-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

Review 1.  Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and meta-analysis of clinical studies.

Authors:  Fabio Cavallaro; Claudio Sandroni; Cristina Marano; Giuseppe La Torre; Alice Mannocci; Chiara De Waure; Giuseppe Bello; Riccardo Maviglia; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2010-05-26       Impact factor: 17.440

2.  End-tidal carbon dioxide is better than arterial pressure for predicting volume responsiveness by the passive leg raising test.

Authors:  Xavier Monnet; Aurélien Bataille; Eric Magalhaes; Jérôme Barrois; Marine Le Corre; Clément Gosset; Laurent Guerin; Christian Richard; Jean-Louis Teboul
Journal:  Intensive Care Med       Date:  2012-09-19       Impact factor: 17.440

3.  Pulse pressure variations to predict fluid responsiveness: influence of tidal volume.

Authors:  Daniel De Backer; Sarah Heenen; Michael Piagnerelli; Marc Koch; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

4.  Influence of respiratory rate on stroke volume variation in mechanically ventilated patients.

Authors:  Daniel De Backer; Fabio Silvio Taccone; Roland Holsten; Fayssal Ibrahimi; Jean-Louis Vincent
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

  4 in total
  1 in total

1.  End-tidal carbon dioxide and arterial pressure for predicting volume responsiveness by the passive leg raising test: reply to Piagnerelli and Biston.

Authors:  Xavier Monnet; Jean-Louis Teboul
Journal:  Intensive Care Med       Date:  2013-04-25       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.